hexobarbital has been researched along with mopidralazine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldoli, E; Bianchi, G; Corsico, N; Di Francesco, GF | 1 |
1 other study(ies) available for hexobarbital and mopidralazine
Article | Year |
---|---|
Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Avoidance Learning; Dogs; Hemodynamics; Hexobarbital; Hypertension, Renal; Indomethacin; Injections, Intravenous; Male; Pentylenetetrazole; Postural Balance; Pyridazines; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Sleep; Species Specificity; Vasodilator Agents | 1985 |